Locomotor Training for Infants at High Risk of Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how infants learn to move in their first 18 months, focusing on those at high risk for cerebral palsy (CP). Researchers will use sensors and robotic tools to observe and support infants as they develop skills like crawling and walking. The trial includes specific training phases, called Prone and Upright Locomotor Training, to help infants progress in their movement abilities. Infants less than six weeks old, with a history of early brain injury linked to CP, and whose families can attend study visits, may be a good fit.
As an unphased trial, this study offers families the chance to contribute to groundbreaking research that could enhance early intervention strategies for infants at risk of CP.
Do I need to stop my baby's current medications for this trial?
The trial protocol does not specify whether you need to stop your baby's current medications. It's best to consult with the trial coordinators for specific guidance.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this locomotor training is safe for infants at high risk of cerebral palsy?
Research shows a lack of specific safety information for certain types of movement training in infants at high risk of cerebral palsy. However, similar studies have found this training to be generally safe. The training uses devices to assist infants in learning to crawl and walk. These methods are non-invasive, meaning they don't involve surgery or entering the body. This trial does not test a new drug but focuses on understanding infant movement development, which typically carries a lower risk of side effects.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel approach to helping infants at high risk for cerebral palsy develop motor skills. Unlike traditional therapies that often focus on interventions after significant delays are evident, this study emphasizes early intervention with prone and upright locomotor training. The treatment uses innovative devices like the Self-Initiated Prone Progression Crawler (SIPPC) and dynamic weight support (DWS) to encourage natural movement patterns from a very young age. By starting early and tailoring interventions to each child's development, this approach has the potential to foster better motor outcomes and possibly reduce the severity of cerebral palsy symptoms.
What evidence suggests that this locomotor training is effective for infants at high risk of cerebral palsy?
Research has shown that special exercises, both lying down and standing up, can improve movement skills in infants at high risk for cerebral palsy (CP). In this trial, infants will engage in a prone locomotor intervention using the Self-Initiated Prone Progression Crawler (SIPPC) to enhance crawling abilities. Additionally, an upright locomotor intervention phase will use dynamic weight support (DWS) to aid infants in learning to walk. Studies indicate that these methods can lead to noticeable improvements in infant movement. Incorporating robotic-assisted training as part of this approach has also shown promise in aiding young children with CP. Early results suggest that beginning this training early might help infants learn to move more effectively.12367
Who Is on the Research Team?
Laura Prosser, PhD
Principal Investigator
Research Scientist
Are You a Good Fit for This Trial?
This trial is for infants under 6 weeks old at high risk for cerebral palsy due to early brain injury. Families must commit to study visits. Infants with certain genetic conditions, normal movement assessments, or better-than-expected motor performance scores are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Early Spontaneous Movement Observation
Observation of early spontaneous leg movements measured monthly
Prone Locomotor Training
Prone locomotor training using the Self-Initiated Prone Progression Crawler (SIPPC)
Upright Locomotor Training
Upright locomotor training with dynamic weight support (DWS)
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Prone and Upright Locomotor Training
Trial Overview
The study tests how babies at risk of cerebral palsy learn to move from birth up to walking age. It uses special robotic and sensor technology over three stages: early movements, crawling (prone locomotion), and walking (upright locomotion).
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This study has three phases. The first phase of the study will be the observation of early spontaneous leg movements which will be measured monthly from 1-4 months of age. The prone locomotor intervention phase using the Self-Initiated Prone Progression Crawler (SIPPC) will occur from 5-9 months of post-term age, or end earlier if the child achieves the ability to crawl six feet. Treatment will occur at an intensity of 3 times per week for 15-30 minutes. Infants will use the SIPPC for the duration of each therapy session The upright locomotor intervention phase using DWS will occur from 9-18 months of age, or begin earlier if the child achieves the ability to crawl six feet before 9 months of age, and end earlier if the child achieves independent walking before 18 months of age. Treatment will occur at an intensity of 3 times per week for 30 minutes. Infants will receive dynamic weight support (DWS) for the duration of the 30-minute therapy session.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
Children's Hospital Los Angeles
Collaborator
University of Oklahoma
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Published Research Related to This Trial
Citations
Locomotor learning in infants at high risk for cerebral palsy
Common across all three stages is the collection of comprehensive robotic, sensor, and behavioral data about how infants at risk for CP move.
Locomotor Learning in Infants at High Risk for Cerebral Palsy
Prone locomotor training using the Self-Initiated Prone Progression Crawler (SIPPC) will be delivered from 5-9 months of age. Upright locomotor training with ...
Locomotor learning in infants at high risk for cerebral palsy
Infants who remain at high risk for CP at 4 months of age, which we expect to be approximately 50% of those enrolled, will progress to novel locomotor training ...
Locomotor Training for Infants at High Risk of Cerebral Palsy
The available research shows that robotic-assisted gait training, a form of Locomotor Training, can lead to moderate to large improvements in movement skills, ...
5.
research.chop.edu
research.chop.edu/cornerstone-blog/cerebral-palsy-and-locomotor-learning-teaching-the-brain-how-to-move-the-bodyCerebral Palsy and Locomotor Learning: Teaching the ...
Laura Prosser, PT, PhD, is leading the first longitudinal study of locomotor learning in infants who are at high risk for cerebral palsy.
Locomotor learning in infants at high risk for cerebral palsy
This study will develop predictive models of locomotor skill acquisition over time. We hypothesize that experiencing and correcting movement ...
7.
researchgate.net
researchgate.net/publication/368771537_Locomotor_learning_in_infants_at_high_risk_for_cerebral_palsy_A_study_protocolLocomotor learning in infants at high risk for cerebral palsy
Prone locomotor training will be delivered from 5 to 9 months of age, followed by upright locomotor training will be delivered from 5 to 9 ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.